Bystronic (BYS) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
26 Feb, 2026Executive summary
Order intake rose 5% at constant exchange rates to CHF 634.5 million, while net sales declined 2.2% year-over-year at constant exchange rates, reflecting persistent market headwinds.
Adjusted EBIT improved to CHF 47 million, while reported EBIT loss narrowed to CHF -19.8 million from CHF -84 million, driven by restructuring and cost reductions.
Restructuring delivered CHF 60 million in annualized savings, with over 600 FTEs reduced and 85% of savings realized in 2024/25.
Positive book-to-bill ratio achieved for the first time in years, resulting in a higher backlog.
ESG progress included a 24% increase in renewable electricity, a 14% reduction in Scope 1 and 2 emissions, and a 28% decrease in workforce injuries.
Financial highlights
EBIT improved to CHF -19.8 million from CHF -84.0 million in the prior year; adjusted EBIT margin improved to -3.2% from -7.3% year-over-year.
Net result improved to CHF -28.9 million from CHF -67.6 million year-over-year.
Operating free cash flow was CHF -18.8 million, impacted by restructuring-related outflows.
Equity ratio increased to 70.4% from 69.2%, with cash and securities at CHF 330.7 million at year-end.
Dividend maintained at CHF 4.00 per class A share, CHF 0.80 per class B share, totaling CHF 8.3 million.
Outlook and guidance
No significant improvement in the overall market environment expected for 2026; focus remains on order intake, backlog, and operational efficiency.
Net sales anticipated to increase in 2026, supported by higher backlog and full consolidation of Bystronic Rofin.
Midterm EBIT margin guidance of 5%-7% reiterated, with profitability in 2026 dependent on net sales recognition and integration of Rofin.
Latest events from Bystronic
- Order intake and sales fell nearly 30%, leading to a record EBIT loss and no recovery expected.BYS
H1 20243 Feb 2026 - Sharp sales and earnings decline led to major restructuring and persistent market headwinds.BYS
H2 202420 Dec 2025 - Order intake stabilized, EBIT loss narrowed 66%, and CHF 60m cost savings are on track.BYS
H1 202516 Nov 2025 - Order intake stable, sales down, with improved operating results expected for 2025.BYS
Q3 2025 TU23 Oct 2025 - Order intake and sales dropped over 25% as restructuring accelerates amid weak demand.BYS
Q3 2024 TU13 Jun 2025